Clinical Trial

Background of Different Phenotypes of Coeliac Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to investigate genetic, serological, immunological and microbiata diversities between different coeliac disease phenotypes and to discover applicable prognostic markers for specific phenotypes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-25; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting 2023-01-04
Trial Details
NCT Number NCT05597904
Lead Sponsor Tampere University Hospital
Collaborators: Tampere University, University of Helsinki, University of Turku, Oulu University Hospital, University of Debrecen, University of Trieste, Oslo University Hospital
Conditions Celiac Disease, Dermatitis Herpetiformis
Enrollment 3,500 participants
Start Date 2022-11-08
Primary Completion 2027-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-17